Life sciences startups often invest significant capital into research and development long before generating stable revenue. For these early-stage companies, strategic tax planning helps preserve cash, extend runway, and maintain hiring goals.
However, conducting innovative science does not automatically establish tax eligibility. Routine laboratory activity is insufficient to claim a benefit, and companies often face IRS scrutiny when they rely on poorly drafted contracts or overlook grant restrictions.
This article outlines how founders and finance teams can build a more defensible approach to the R&D tax credit. By addressing agreement structures and internal records early, companies can reduce audit risks and establish a more reliable factual basis for their filings.
What the R&D Tax Credit Covers
The federal R&D tax credit applies to certain eligible expenses tied to U.S.-based research activities intended to resolve technical uncertainty. The tax code rewards certain domestic research, but not all work performed by a scientific or laboratory-based business automatically qualifies.
The IRS expects eligible activities to follow a defined process of experimentation. As reporting and disclosure requirements grow more detailed, companies cannot rely on rough estimates. Instead, they must support their filings with a legally sound factual basis.
Why R&D Tax Credit Planning Matters for Life Sciences Startups
Approaching the R&D tax credit strategically serves several critical business functions for life sciences leadership:
- Cash preservation: Early-stage companies can sometimes offset payroll taxes, directly keeping more capital in the business.
- Runway extension: Recovered funds can be redirected into critical discovery phases or key personnel.
- Internal alignment: Proper planning helps legal, finance, and operations teams coordinate how laboratory projects are tracked.
- Mistake prevention: Early evaluation exposes problematic contract terms and weak records before they trigger an IRS examination.
- Operational discipline: A planned approach integrates compliance into everyday workflows rather than treating it as a rushed retroactive task.
Where Life Sciences Startups Often Have the Strongest Credit Position
A strong basis for a claim typically rests on work tied to resolving technical challenges and advancing a product or process. Startups should look closely at areas where they are actively testing competing methods, resolving formulation instability, refining device functionality, or adjusting process parameters to overcome performance issues.
Preclinical Research and Product Development Activities
The core discovery phases often provide the clearest examples of eligible activities. While a deeper factual analysis is always required, claims are generally stronger in these areas when well-documented:
- Formulation work and active pharmaceutical ingredient testing.
- Assay development and validation.
- Prototype refinement for medical devices or diagnostic tools.
- Testing necessary to overcome clear technical hurdles.
- Product development work was conducted before commercialization.
Process Improvement and Technical Development Work
The credit is not limited to new products. It can also apply to how a product is manufactured, provided the effort solves engineering or scientific problems rather than merely optimizing ordinary production. This includes:
- Manufacturing process development.
- Technical workflow refinement in laboratory settings.
- Engineering improvements for specialized testing equipment.
- Adjustments necessary to resolve design or method failures.
Certain life sciences activities typically present a much clearer factual basis for the credit than others.
| Activity Type | Often Stronger Credit Position | Why It May Be Stronger | Caution |
| New Formulation | Yes | Heavily relies on experimentation to resolve technical variables. | Documentation must track the specific hypotheses and test results. |
| Assay Development | Yes | Involves iterative design and technical testing. | Must be tied to a specific business component, not general research. |
| Process Scale-Up | Yes | Adapting a lab process to manufacturing often creates new engineering challenges. | Routine troubleshooting after the scale-up is complete typically does not count. |
What to Review Before Claiming the R&D Credit
A startup must conduct a practical internal readiness check before pursuing a claim. This screening ensures the business has the right operational foundation to move forward responsibly.
Company Stage, Revenue Profile, and Payroll Tax Eligibility
The company stage dictates how a tax benefit is actually utilized. Pre-revenue companies without income tax liability may still monetize the credit through a payroll tax election to offset certain employer taxes. Because this benefit is limited by company age and gross receipts, leadership must verify their specific tax posture to confirm availability.
Internal Recordkeeping and Practical Operations
Leadership must evaluate whether the business efficiently tracks expenses and activities at the project level. Identifying the use of external contractors or outside funding early helps spot obvious compliance issues before committing to a full credit study.
How CRO Agreements, Grants, and Research Partnerships Can Affect Eligibility
Because life sciences companies frequently rely on outside partners, contractual structure dictates tax outcomes just as much as the underlying science. The terms found in CRO agreements, university collaborations, sponsored research contracts, and licensing structures are critical to establishing a reliable claim.
This legal analysis focuses heavily on several key factors:
- Economic risk: Payment structure dictates who actually bears the financial burden if the research fails.
- Substantial rights: The startup must retain meaningful intellectual property rights in the results, rather than surrendering them to a commercial partner.
- Funding constraints: Grants, sponsored research, and partner-funded arrangements may restrict a company from claiming the associated costs.
- Agreement review: All external contracts should be reviewed to verify risk and rights allocation before treating vendor invoices as eligible expenses.
Which Expenses Life Sciences Startups Can Usually Include and Which Usually Cannot
Identifying the correct expenses requires strict adherence to federal definitions. While every company’s situation is unique, costs generally fall into standard categories of inclusion or exclusion.
| Expense Category | Often Included | Notes |
| Wages | Yes | Includes certain taxable wages reported on Form W-2 for employees directly performing, supervising, or supporting eligible research. |
| Supplies | Yes | Tangible property used and consumed directly in the research process. |
| Contract Research | Yes | Must meet specific contract terms regarding risk and rights. Only a statutory percentage of eligible contract research costs is typically counted. |
| Overhead & Rent | No | General facility rent, utilities, and administrative overhead do not count. |
| Depreciable Assets | No | Equipment purchases (like laboratory machinery) must be depreciated and are not considered research supplies. |
Ultimately, appropriate expense treatment relies on how the work was actually performed in practice, not just how an invoice was labeled.
Which Activities Usually Create More Audit Risk
As a startup moves past the initial discovery phase and closer to commercialization, the nature of its work often shifts. This progression naturally attracts more IRS scrutiny, as tax authorities closely examine operational categories that resemble ordinary business activities.
Regulatory, Quality Control, and Post-Commercial Activities
Examination risk rises significantly when work moves toward compliance or routine production. High-risk areas include regulatory submission support, routine quality control testing, and post-commercial troubleshooting. Activities driven primarily by market research or administrative requirements rather than scientific discovery are common targets for auditors.
Funded, Foreign, and Weakly Documented Research
The IRS also looks closely at specific fact patterns regarding funding and location.
- Foreign research: Research performed outside the United States does not count for the federal credit.
- Funded research: Grant-funded or externally subsidized work raises immediate concerns that demand separate legal review.
- Weak substantiation: Broad estimates of employee time lacking tangible backing present a clear compliance vulnerability.
How Federal Payroll Tax Elections and State Credits Can Increase Total Value
A strategic approach to planning should also consider how different mechanisms impact early-stage liquidity. The federal payroll tax election is highly valuable because it allows qualifying startups to monetize the credit against payroll taxes well before they generate taxable income.
At the local level, state R&D tax credits can further increase this financial benefit. However, because state regulations often diverge from federal rules, leadership must evaluate these incentives independently to maximize their overall value.
What Audit-Ready Documentation Looks Like
A company should build its records during the actual work rather than attempting to reconstruct them at the last minute. The IRS expects contemporaneous books and records that directly link laboratory activities to claimed costs.
Technical Records Supporting Qualified Research
Strong technical substantiation requires project-level records that show how the work was performed and why it may qualify. This should typically include:
- Defined technical problem: Records identifying the initial scientific or engineering uncertainty.
- Development history: Project files showing how the work progressed over time.
- Testing records: Laboratory notes or similar materials documenting both successful and unsuccessful iterations.
- Business component linkage: Support connecting the technical work to a relevant product, process, formula, technique, or similar business component.
Financial, Payroll, and Contractor Support
Financial documentation helps support the credit calculation by showing who performed the work, how costs were classified, and whether contractor expenses can be tied to specific projects. This includes:
- Payroll support: Records detailing employee compensation.
- Role tracking: Internal data distinguishing technical work from administrative activity.
- Contractor records: Invoices and statements of work tied to specific research projects.
- Expense linkage: Internal summaries connecting claimed costs directly to the work performed.
Common Mistakes When Claiming R&D Credits
Claiming this tax benefit involves more than just identifying strong science. Startups often weaken otherwise credible filings by grouping unlike activities together, relying on broad estimates, or waiting too long to organize their files.
- Over-inclusion: Treating all laboratory-related work as automatically eligible.
- Poor activity separation: Failing to distinguish development work from routine quality control or regulatory support.
- Contract blind spots: Not evaluating CRO agreements or vendor terms before including related expenses.
- Funding assumptions: Assuming grant-supported work can be claimed without a closer legal analysis.
- Retroactive documentation: Waiting until tax season to recreate records instead of building them during the work itself.
- Unsupported allocations: Using broad employee-time percentages without project-level backing.
- State-credit assumptions: Treating state rules as identical to the federal position.
How Crowley Law Helps Approach R&D Credit Planning
Crowley Law LLC provides attorney-led legal counsel to life sciences companies, focusing on the contractual architecture that ultimately supports a tax position. We review CRO agreements, licensing terms, contractor arrangements, and research partnerships to analyze intellectual property ownership and financial risk allocation.
Identifying these structural vulnerabilities early allows leadership to address legal weaknesses before a tax claim is prepared. Our review helps ensure contract terms align with the company’s operations, funding structure, and broader tax strategy. By resolving ownership and funding issues upfront, we help build a more defensible foundation well before return preparation begins.
Contact Us | Schedule a Consultation
Frequently Asked Questions (FAQs)
| Question | Answer |
| Do all life sciences research activities qualify for the R&D tax credit? | No. Eligible activities must meet a strict four-part statutory test. Routine testing and post-commercial activities generally do not count. |
| Can a pre-revenue startup still benefit from the credit? | Yes. Certain qualified small businesses can make a payroll tax election to offset employer payroll taxes, providing near-term cash flow relief. |
| How do CRO agreements affect R&D tax credit eligibility? | They can significantly impact the claim. The startup must bear the economic risk of the research and retain substantial rights to the results. |
| Do grant-funded research activities create issues for a claim? | Yes. Research funded by grants or third parties is generally considered “funded research” and often raises concerns that require careful review. |
| What kind of documentation should a startup keep? | Startups need contemporaneous records. This includes laboratory notes, testing data, payroll files, and contractor invoices directly tied to eligible projects. |
| Do state R&D credits follow the same rules as the federal credit? | Not always. While many states align closely with federal definitions, they often have unique requirements and filing timelines that demand independent review. |